Christian Leiber

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nimitha R. Mathew, Francis Baumgartner, Lukas M. Braun et al. · Nature Medicine · 2018 · 283 citations · Full text

Cell Therapy, Flt3-itd-mutant Leukemia Cells, Immunology +7

ADJUVANT INTRAVESICAL TREATMENT OF SUPERFICIAL BLADDER CANCER WITH A STANDARDIZED MISTLETOE EXTRACT

Ursula Elsässer‐Beile, Christian Leiber, Philipp Wolf et al. · The Journal of Urology · 2005 · 61 citations

SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11)

Margitta Retz, Jens Bedke, Martin Bögemann et al. · European Journal of Cancer · 2018 · 30 citations

Urology, Sorafenib-pazopanib Versus Pazopanib-sorafenib, Genitourinary Cancer +10

Comparison of the activation status of tumor infiltrating and peripheral lymphocytes of patients with adenocarcinomas and benign hyperplasia of the prostate

Ursula Els�sser-Beile, Boris Przytulski, Dorothee Gierschner et al. · The Prostate · 2000 · 29 citations

Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up

Cordula A. Jilg, Hartmut P.H. Neumann, Sven Gläsker et al. · Familial Cancer · 2012 · 27 citations

Urology, Surgical Oncology, Genitourinary Cancer +9